Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Walgreens Boots Alliance announced a binding offer from Fareva for a 10-year global agreement for the manufacture and supply of own beauty brands and private label products.
read more
The WACKER chemical group headquartered in Munich has acquired 100 percent of the shares of contract manufacturing company (CMO) ADL BioPharma.
read more
Wacker Biotech US, a subsidiary of WACKER, specializing in the fermentative production of plasmid DNA (pDNA), is expanding its mRNA and protein production.
read more
As a consequence of the initial vaccine shortages in the coronavirus pandemic, the German government is securing vaccine production and supplies for the years ahead.
read more
VWR a global independent provider of product and service solutions to laboratory and production customers has celebrated the opening of its Solon, Ohio manufacturing site. City officials and other distinguished attendees enjoyed a facility tour and ...
read more
Avantor and VWR announced they have entered into a definitive agreement under which Avantor will acquire VWR for $33.25 in cash per share of VWR common stock, reflecting an enterprise value of approximately $6.4 billion.
read more
Wednesday, December 27, 2017
Vuzix announced the company has expanded its sales footprint in the Biopharmaceutical industry by way of recent M300 Smart Glasses deliveries to a Fortune-100 pharmaceutical company.
read more
Tuesday, December 29, 2020
vTv Therapeutics has entered into a licensing agreement with Anteris Bio for worldwide rights to vTv’s novel clinical-stage Nrf2 activator compound, HPP971.
read more
VTT has started work on a new testing method based on detection of viral antigens for the COVID-19-virus.
read more
Wednesday, December 05, 2018
Voyager Therapeutics, a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, has entered into collaborations with Brammer Bio (Brammer) and Fujifilm Diosynth Biotechnologies (Fujifilm) ...
read more
VolitionRx has opened its new research and development facility in Belgium.
read more
Wednesday, January 06, 2016
Voisin Consulting Life Sciences, a global healthcare product development consultancy, and iQone Healthcare, a specialty pharmaceutical company focused on pharmaceutical distribution, sales, marketing and contract services in Europe, have announced a ...
read more
Wednesday, February 13, 2019
Vizient announces it will create a centralized item master tool for a supply chain innovation program envisioned by the Captis network of member hospitals and providers.
read more
Viz.ai, a provider of AI-powered disease detection and intelligent care coordination, announced a De Novo approval by the FDA for its Viz HCM module, a hypertrophic cardiomyopathy (HCM) artificial intelligence (AI) detection algorithm, creating a new...
read more
Wednesday, November 16, 2022
Viz.ai, a provider of AI-powered disease detection and intelligent care coordination, announced a strategic partnership with Vastrax, a full-service, vascular clinical research organization (CRO).
read more